期刊
MOLECULAR CARCINOGENESIS
卷 58, 期 10, 页码 1897-1907出版社
WILEY
DOI: 10.1002/mc.23083
关键词
epidermal growth factor receptor; hepatocellular carcinoma; metastasis; PI3K-AKT; tropomodulin 3
资金
- National Key Basic Research Program of China [2014CB542102]
- Shanghai Health and Family Planning Commission Foundation [2017ZX10203208, 20164Y0189]
- National Human Genetic Resources Sharing Service Platform [2005DKA21300]
- Science Fund for Creative Research Groups, NSFC, China [81521091]
- State Key Infection Disease Project of China [2017ZX10203208]
The mechanism of hepatocellular carcinoma (HCC) metastasis remains poorly understood. Tropomodulin 3 (TMOD3) is a member of the pointed end capping protein family that contributes to invasion and metastasis in several types of malignancies. It has been found to be crucial for the membranous skeleton and embryonic development, although, its role in HCC progression remains largely unclear. We observed increased levels of Tmod3 in HCCs, especially in extrahepatic metastasis. High Tmod3 expression correlated with aggressive carcinoma and poor patient with HCC survival. Loss-of-function studies conducted by us determined Tmod3 as an oncogene that promoted HCC growth and metastasis. Mechanistically, Tmod3 increases transcription of matrix metalloproteinase-2, -7, and -9 which required PI3K-AKT. Interaction between Tmod3 and epidermal growth factor receptor (EGFR) that supports the activation of EGFR phosphorylation, is essential for signaling activation of PI3K-AKT viral oncogene homolog. These findings reveal that Tmod3 enhances aggressive behavior of HCC both in vitro and in vivo by interacting with EFGR and by activating the PI3K-AKT signaling pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据